CMBA
GILD icon

C.M. Bidwell & Associates’s Gilead Sciences GILD Stock Holding History

C.M. Bidwell & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,175
Closed -$390K – 498
2025
Q4 		$390K Sell
3,175
-104
-3% -$12.6K 0.18% 74
2025
Q3 		$364K Sell
3,279
-282
-8% -$32.1K 0.18% 79
2025
Q2 		$395K Sell
3,561
-180
-5% -$19.2K 0.2% 75
2025
Q1 		$419K Sell
3,741
-60
-2% -$6.19K 0.25% 68
2024
Q4 		$351K Buy
+3,801
New +$342K 0.21% 77
2024
Q1 		– Sell
-2,695
Closed -$218K – 505
2023
Q4 		$218K Buy
2,695
+15
+0.6% +$1.17K 0.16% 111
2023
Q3 		$201K Buy
+2,680
New +$206K 0.15% 116
2019
Q1 		– Sell
-8,525
Closed -$533K – 424
2018
Q4 		$533K Buy
+8,525
New +$596K 0.58% 38
2016
Q2 		– Sell
-40,190
Closed -$3.69M – 273
2016
Q1 		$3.69M Buy
+40,190
New +$3.62M 0.92% 54
2015
Q3 		– Sell
-48,300
Closed -$5.66M – 253
2015
Q2 		$5.66M Sell
48,300
-3,040
-6% -$332K 1.26% 17
2015
Q1 		$5.04M Sell
51,340
-41,250
-45% -$4.19M 1.11% 27
2014
Q4 		$8.73M Sell
92,590
-555
-0.6% -$57.4K 1.99% 4
2014
Q3 		$9.91M Sell
93,145
-465
-0.5% -$45.5K 2.34% 1
2014
Q2 		$7.76M Buy
+93,610
New +$7.29M 1.77% 8

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

C.M. Bidwell & Associates's GILD Position: Q1 2026 in Review

C.M. Bidwell & Associates sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 3,175 shares — an estimated $390K sold.

C.M. Bidwell & Associates first reported a position in GILD in Q2 2014 and held it in 14 quarters. The position peaked at $9.91M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • C.M. Bidwell & Associates reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 3,175 Gilead Sciences shares in Q1 2026, an estimated $390K.
  • C.M. Bidwell & Associates first reported a position in Gilead Sciences in Q2 2014 and held it in 14 quarters.
  • C.M. Bidwell & Associates's Gilead Sciences position peaked at $9.91M in Q3 2014.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.